# A Phase I Study to Assess the Safety and Immunogenicity of ChAd63 ME-TRAP - MVA ME-TRAP Heterologous Prime-boost Vaccination Co-administered With EPI Vaccines in Gambian Infants

> **NCT02083887** · PHASE1 · COMPLETED · sponsor: **University of Oxford** · enrollment: 65 (actual)

## Conditions studied

- Malaria

## Interventions

- **BIOLOGICAL:** ChAd63 ME-TRAP / MVA ME-TRAP

## Key facts

- **NCT ID:** NCT02083887
- **Lead sponsor:** University of Oxford
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-02
- **Primary completion:** 2015-11
- **Final completion:** 2015-11
- **Target enrollment:** 65 (ACTUAL)
- **Last updated:** 2015-12-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02083887

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02083887, "A Phase I Study to Assess the Safety and Immunogenicity of ChAd63 ME-TRAP - MVA ME-TRAP Heterologous Prime-boost Vaccination Co-administered With EPI Vaccines in Gambian Infants". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02083887. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*